Azitra, Inc. (AZTR) vs Creative Medical Technology Holdings, Inc. (CELZ)

Azitra, Inc. and Creative Medical Technology Holdings, Inc. are both Biotechnology companies. Azitra, Inc. and Creative Medical Technology Holdings, Inc. are of similar size ($4.4M and $4.0M). Creative Medical Technology Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Azitra, Inc. trades at 1.3×. Azitra, Inc. grew revenue faster over the last twelve months: 58.2% against −79.4%. Across the 14 metrics below, Azitra, Inc. leads on 8 and Creative Medical Technology Holdings, Inc. on 6.

Valuation

Metric AZTR CELZ Biotechnology median
P/E 1.27 n/m 10.60
P/S 2.50 135.00 9.40
P/B 0.20 0.26 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.47 1.05 0.66
EV/Sales (9.10) (377.99) 9.02
Earnings yield 78.60% (333.87%) (32.88%)
Free cash flow yield (786.51%) (489.01%) (23.13%)

Profitability

Metric AZTR CELZ Biotechnology median
Gross margin 100.00% 61.18% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (256.67%) (77.91%) (51.96%)
Return on assets (190.69%) (73.30%) (46.06%)
Return on invested capital (1,272.49%) 0.00% 0.00%

Growth

Metric AZTR CELZ Biotechnology median
Revenue growth (TTM) 58.18% (79.42%) 6.76%
EPS growth (last fiscal year) 85.68% 32.08% 29.88%
Revenue growth, 5-year CAGR — (48.43%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AZTR CELZ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.86 12.91 4.97
Net debt to EBITDA 0.20 1.20 1.01

Dividend

Metric AZTR CELZ Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AZTR CELZ Biotechnology median
Market cap 4.39m 4.00m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack